RELAXO NSE filing

Relaxo Footwears Q4 FY26: Revenue up 8.1% to ₹751 Cr, PAT jumps 20.4% to ₹68 Cr

The RealCase readHigh impact Positive

Relaxo Footwears reported Q4 FY26 revenue of ₹751 crore, up 8.1% YoY. PAT increased 20.4% to ₹68 crore. For FY26, revenue was ₹2,702 crore and PAT was ₹179 crore. The company plans to open 100 new EBOs and has budgeted ₹180-200 crore for capex in FY27. Management aims for over 1% operating margin improvement.

Why it matters

The announcement includes key financial performance metrics (revenue, profit, margins) for the quarter and full year, along with strategic growth initiatives like EBO expansion and capex plans, which are material for investors.

The market read

The company reported positive year-on-year growth in revenue, EBITDA, and PAT for both the quarter and the full financial year. Management expressed optimism for the future and outlined strategic growth plans, indicating a positive outlook.

Relaxo Footwears Limited announced its financial results for the fourth quarter and full financial year ended March 31, 2026. The company reported a revenue from operations of ₹751 crore for Q4 FY26, an increase of 8.1% year-on-year from ₹695 crore in Q4 FY25. This growth was attributed to strong volume growth, a recovery in general trade, and continued expansion in retail, e-commerce, and large-format retail channels.

EBITDA for the quarter stood at ₹124 crore, a 10.6% year-on-year increase, with EBITDA margins at 16.5%, up from 16.1% in the previous year. Profit after tax (PAT) for Q4 FY26 grew by 20.4% to ₹68 crore from ₹56 crore in Q4 FY25, with PAT margins expanding by 92 basis points to 9.0%.

For the full financial year FY26, revenue from operations was ₹2,702 crore, compared to ₹2,790 crore in FY25. EBITDA for FY26 was ₹374 crore, with an EBITDA margin of 13.8%. PAT for FY26 stood at ₹179 crore, a 5.3% increase from ₹170 crore in FY25, and PAT margin improved to 6.6% from 6.1%.

The company management expressed cautious optimism for FY27, acknowledging potential inflationary pressures but committed to sustainable performance. During the earnings call, management discussed passing on price increases of 15-18% to offset cost inflation, which they estimated at 15-20% on the cost side. They also highlighted plans for premiumization, expanding the product mix with higher price points, and opening 100 new Exclusive Business Outlets (EBOs) with a planned capex of ₹180-200 crore for FY27. The company aims to improve operating margins by over 1% from the previous year's 13.8%.

Filing to action

What to do with a filing like this

Relaxo Footwears Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Relaxo Footwears Limited. Read the original for the full detail.

View original filing